No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6880233 |
chr5:35850693-35850694 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs77636995 |
chr5:35850714-35850715 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs569038273 |
chr5:35850808-35850809 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs568052194 |
chr5:35850823-35850824 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs181644186 |
chr5:35850850-35850851 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs557635477 |
chr5:35850890-35850891 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs537084232 |
chr5:35850938-35850939 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs116748874 |
chr5:35850988-35850989 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs76933815 |
chr5:35850989-35850990 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs186441082 |
chr5:35850990-35850991 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs573443531 |
chr5:35850995-35850996 |
Enhancers Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs189281149 |
chr5:35851016-35851017 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs562537489 |
chr5:35851050-35851051 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs550381795 |
chr5:35851084-35851085 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs181743004 |
chr5:35851089-35851090 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs544909764 |
chr5:35851131-35851132 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs148687079 |
chr5:35851151-35851152 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs533572833 |
chr5:35851176-35851177 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs570549607 |
chr5:35851179-35851180 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs528983613 |
chr5:35851197-35851198 |
Enhancers Active TSS Flanking Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs542679133 |
chr5:35851223-35851224 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs142236892 |
chr5:35851226-35851227 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs538823754 |
chr5:35851255-35851256 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs12516866 |
chr5:35851261-35851262 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs529438109 |
chr5:35851305-35851306 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs368536703 |
chr5:35851362-35851363 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs11952240 |
chr5:35851383-35851384 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs569251569 |
chr5:35851410-35851411 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs528683751 |
chr5:35851423-35851424 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs537722737 |
chr5:35851436-35851437 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs558037072 |
chr5:35851437-35851438 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs571069837 |
chr5:35851453-35851454 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs533729846 |
chr5:35851468-35851469 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs114319163 |
chr5:35851488-35851489 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs566846266 |
chr5:35851491-35851492 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs369129908 |
chr5:35851501-35851502 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs573386398 |
chr5:35851516-35851517 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs185082171 |
chr5:35851533-35851534 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs114983382 |
chr5:35851591-35851592 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs190659871 |
chr5:35851628-35851629 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs147824044 |
chr5:35851683-35851684 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs564758489 |
chr5:35851694-35851695 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs372295398 |
chr5:35851706-35851707 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs141374202 |
chr5:35851728-35851729 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs560704933 |
chr5:35851745-35851746 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs183343924 |
chr5:35851747-35851748 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs186306066 |
chr5:35851773-35851774 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs1494564 |
chr5:35851831-35851832 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs558675678 |
chr5:35851885-35851886 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs551525344 |
chr5:35851959-35851960 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|